Sign Up to Receive Your Personalised Learning Resources
![](https://www.touchrespiratory.com/wp-content/uploads/sites/11/2023/09/thumbnail_touchRESP-1-800x450.png)
touchEXPERT OPINIONS
The mRNA vaccine platform: A novel tool for the rapid development of vaccines against respiratory viral infections
Start Learning
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Gefapixant for the treatment of chronic cough – a dose-response analysis: Elena Kum, ERS 2023
View
Overcoming challenges in advanced or metastatic squamous cell lung cancer: Focus on immunotherapy
View
Current treatments and unmet needs in limited-stage small cell lung cancer
View
The Changing Landscape of Surgical Treatment for Early-stage Non-small Cell Lung Cancer
View
Personalized therapy for NSCLC: Biomarker testing, treatment and management in the presence of MET alterations
View
Analysis of gefapixant efficacy and safety by history of refractory or unexplained chronic cough: Imran Satia, ERS 2023
View
The mRNA vaccine platform: A novel tool for the rapid development of vaccines against respiratory viral infections
View
Advances in understanding COPD
View
Acetazolamide to prevent altitude-related adverse health effects in COPD: Michael Furian, ERS 2023
View
Contemporary insights on the management of sickle cell disease: Focus on complications and recent advances in therapy
View